2012ESC STEAMI 诊治指南更新 解放军总医院心血管病中心 杨庭树 2012.09.14.

Slides:



Advertisements
Similar presentations
Myocardial infarction New concepts New definitions.
Advertisements

A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
Coronary Artery Disease. What is coronary artery disease? A narrowing of the coronary arteries that prevents adequate blood supply to the heart muscle.
Ischemic Heart Diseases IHD
Acute Coronary Syndrome Update
Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Updates in Acute Coronary Syndromes Management
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults p.o.box zip code Done by: Dr.Amin Zagzoog.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
Indication and contra-indications for cardiac catheterization
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Ischemic heart disease Basic Science 3/15/06. All of the following concerning coronary artery anatomy are correct except: The left main coronary artery.
VBWG HPS. Lancet. 2003;361: Gæde P et al. N Engl J Med. 2003;348: Recent statin trials: Reduction in primary outcome in patients with diabetes.
1 CCORT/CCS 2008 Quality Indicators for Acute Myocardial Infarction (AMI) Care-Indicator Definitions CIHR Team Grant in Cardiovascular Outcomes Research.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. MYOCARDIAL INFARCTION Prof.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy) Clinical Correlates and Mayo Clinic Risk Score Malini Madhavan, MBBS;
Update of 2013 ACCF/AHA Guidelines for STEMI Junbo Ge MD,FACC,FESC,FSCAI Zhongshan Hospital, Fudan University.
Acute Coronary Syndromes
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
IABP用于高危PCI有价值吗? Is IABP Valuable for High-Risk PCI?
Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure REMINDER* Gilles Montalescot, Bertram Pitt,
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Cost Containment: Use of Troponin testing in the Inpatient Wards Setting Neal Kaushal, R2 DSR2, May 2013.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Cardiac causes of cardiac arrest
Total Occlusion Study of Canada (TOSCA-2) Trial
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Improving Outcomes in Cardiogenic Shock
By Saranya Temprasertrudee M.D.
CORONARY ARTERY DISEASE
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Management of ST-Elevation Myocardial Infarction
Ischaemic Heart Disease Acute Coronary Syndrome
Nursing Management: Patients With Coronary Vascular Disorders
Chapter 28 Management of Patients With Coronary Vascular Disorders
James S. Kennedy, MD, CCS, CDIP President and Chief Medical Officer
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
European Heart Association Journal 2007 April
Section 5: Intervention and drug therapy
European Society of Cardiology 2003
Published in the European Heart Journal
The European Society of Cardiology Presented by RJ De Winter
Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.
These slides highlight a report from a Hotline Session and a Satellite symposium held at the European Society of Cardiology Congress, 2003 in Vienna Austria,
Management of AMI in patients presenting with STEMI
Cardiovascular Epidemiology and Epidemiological Modelling
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

2012ESC STEAMI 诊治指南更新 解放军总医院心血管病中心 杨庭树

What is new? Early Diagnosis Expanded section, atypical presentations Cardiac Arrest Expanded section. The role of therapeutic hypothermia and angiography defined. Pre Hospital Logistics of Care Role of pre hospital diagnosis, triage and networks highlighted Reperfusion strategies Modified recommended maximal time delays, angio post fibrinolysis PCI strategies Stent recommendations, anti thrombotic therapy Routine therapies and strategies Duration of hospital stay, secondary prevention, duration of anti thrombotic therapy, Evaluation of LV function and viability European Heart Journal doi: /eurheartj/ehs215

更新指南明确将心肌梗死分为 5 个类型 I 型 自发性心肌梗死; Ⅱ型 继发性心肌梗死; Ⅲ型 心脏性猝死; Ⅳ a 型 PCI 相关性心梗; Ⅳ b 型 支架内血栓相关心梗; Ⅴ型 冠脉搭桥术相关心梗。 Early Diagnosis

Spontaneous myocardial infarction related to atherosclerotic plaque rupture, fissuring, or dissection with resulting intraluminal thrombus in one or more coronary arteries leading to decreased myocardial blood flow with ensuing myocyte necrosis.

Myocardial Infarction Type 2 Myocardial infarction where a condition other than CAD contributes to an imbalance between myocardial oxygen supply and/or demand, e.g. coronary artery spasm, tachy- /brady-arrhythmia, anaemia, respiratory failure, hypotension or hypertension.

Myocardial Infarction Type 3 Cardiac death with symptoms suggestive of myocardial ischemia and presumed new ischemic ECG changes or new LBBB but death occurring before blood samples could be obtained or before cardiac biomarkers could rise.

Myocardial Infarction Type 4a PCI-related MI is defined by elevation of cardiac troponin values >5 X 99 th percentile URL. In addition, either (i) symptoms suggestive of myocardial ischemia or (ii) new ischaemic ECG changes or (iii) angiographic findings consistent with a procedural complication or (iv) imaging demonstration of new loss of viable myocardium or new regional wall motion abnormality. R

Myocardial Infarction Type 4b Myocardial infarction related to stent-thrombosis is detected by coronary angiography or autopsy in the setting of myocardial ischemia and with a rise and/or fall of cardiac biomarkers with at least one value >99 th percentile URL. R

Myocardial Infarction Type 5 CABG-related MI is defined by elevation of cardiac troponin values >10 X 99 th percentile URL. In addition, either (i) new pathological Q waves or new LBBB, or (ii) angiographic documented new graft or new native coronary artery occlusion, or (iii) imaging evidence of new loss of viable myocardium or new regional wall motion abnormality

Cardiac arrest European Heart Journal doi: /eurheartj/ehs215

Components of delay in STEMI and ideal time intervals for intervention European Heart Journal doi: /eurheartj/ehs215 关键:尽量缩短两个 “ 延迟 ”

Prehospital and in-hospital management, and reperfusion strategies within 24 h of FMC European Heart Journal doi: /eurheartj/ehs215

Important delays and treatment goals in the management of acute STEMI European Heart Journal doi: /eurheartj/ehs215

Reperfusion therapy European Heart Journal doi: /eurheartj/ehs215

Procedural aspects of primary PCI European Heart Journal doi: /eurheartj/ehs215

Periprocedural anti thrombotic medication in primary PCI European Heart Journal doi: /eurheartj/ehs215

Periprocedural anti thrombotic medication in primary PCI, con’t European Heart Journal doi: /eurheartj/ehs215

Periprocedural anti thrombotic medication in primary PCI, con’t European Heart Journal doi: /eurheartj/ehs215

Emergency revascularization with either PCI or CABG in suitable patients must be considered. I A Fibrinolysis should be considered if revascularization is unavailable. IIaC Intra-aortic balloon pumping may be considered.IIbB LV assist devices may be considered for circulatory support in patients in refractory shock. IIb C Treatment of cardiogenic shock (Killip class IV) A recent meta-analysis examined three randomized trials comparing a percutaneous LVAD vs. IABP in a total of 100 patients. Although the LVAD appeared safe and demonstrated better haemodynamics, there was no improvement in 30-day mortality.

Specialized electrophysiological evaluation of ICD implantation for secondary prevention of sudden cardiac death is indicated in patients with significant LV dysfunction, who suffer from haemodynamically unstable sustainedVT or who are resuscitated from VF occurring beyond the initial acute phase I A Secondary preventive ICD therapy is indicated to reduce mortality in patients with significant LV dysfunction, and haemodynamically unstable sustainedVT or survivedVF, not occurring within the initial acute phase. IA Risk evaluation for sudden cardiac death should be performed to assess indication for primary preventive ICD therapy by assessing LVEF (from echocardiography) at least 40 days after the acute event in patients with LVEF ≤40%. IIaC Management of ventricular arrhythmias and risk evaluation for sudden death on long term

Routine therapies in the acute, subacute and long term phase of STEMI European Heart Journal doi: /eurheartj/ehs215

Routine therapies in the acute, subacute and long term phase of STEMI European Heart Journal doi: /eurheartj/ehs215

Routine therapies in the acute, subacute and long term phase of STEMI European Heart Journal doi: /eurheartj/ehs215 A fasting lipid profile must be obtained in all STEMI patients, as soon as possible after presentation. I C It is recommended to initiate or continue high dose statins early after admission in all STEMI patients without contraindication or history of intolerance, regardless of initial cholesterol values. IA Reassessment of LDL-cholesterol should be considered after 4–6 weeks to ensure that a target value of ≤1.8 mmol/L(70 mg/dL) has been reached. IIaC ACE inhibitors are indicated starting within the first 24 h of STEMI in patients with evidence of heart failure, LV systolic dysfunction, diabetes or an anterior infarct. IA

Routine therapies in the acute, subacute and long term phase of STEMI European Heart Journal doi: /eurheartj/ehs215 An ARB, preferably valsartan, is an alternative to ACE inhibitors in patients with heart failure or LV systolic dysfunction, particularly those who are intolerant to ACE inhibitors. I B ACE inhibitors should be considered in all patients in the absence of contraindications. IIaA Aldosterone antagonists, e.g. eplerenone, are indicated in patients with an ejection fraction ≤40% and heart failure or diabetes, provided no renal failure or hyperkalaemia. IB

THANKS!